Scarica l'app Stockscreener
86.41
14.42%
10.89
Dopo l'orario di chiusura:
87.93
1.52
+1.76%
Precedente Chiudi:
$75.52
Aprire:
$82.02
Volume 24 ore:
2.08M
Relative Volume:
2.23
Capitalizzazione di mercato:
$3.11B
Reddito:
$117.67M
Utile/perdita netta:
$-1.88B
Rapporto P/E:
-1.4274
EPS:
-60.5369
Flusso di cassa netto:
$-621.36M
1 W Prestazione:
+21.48%
1M Prestazione:
+122.79%
6M Prestazione:
+226.08%
1 anno Prestazione:
+503.42%
Intervallo 1D:
$82.00
$89.57
Intervallo di 1 settimana:
$65.27
$89.57
Portata 52W:
$12.76
$89.57
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
(833) 694-2553
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Confronta GRAL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
86.41 | 2.50B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Grail Inc Borsa (GRAL) Ultime notizie
Grail Soars on $110 Million Samsung Investment to Commercialize Cancer Test in Asia - NAI500
Samsung invests $110M in GRAIL's cancer detection tech - 조선일보
Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL’s Galleri®Multi-Cancer Early Detection Test to Asia - Samsung Newsroom
Samsung Electronics, Samsung C&T to Invest $110 Million in US-based Biotechnology Firm Grail - MarketScreener
Samsung Electronics, Samsung C&T to invest US$110 mln in U.S. biotech firm Grail - Yonhap News Agency
Samsung will be a strategic investor in GRAIL, an American biotechnology company that has technology.. - 매일경제
Why Grail Stock Soared 14% Higher on Thursday - MSN
Ragusa, Grail Inc. CEO, sells $498k in shares - Investing.com
Ofman Joshua J. sells GRAIL shares worth $1.17 million By Investing.com - Investing.com UK
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News - ts2.tech
Grail Stock Jumps 14% After Samsung Partnership To Launch Galleri Test In Asia - Nasdaq
Grail hits record high after Samsung backs rollout of cancer test in Asia - TradingView
Samsung Elec, Samsung C&T to invest $110 million in healthcare company Grail - MarketScreener
Grail stock surges after Samsung announces $110 million investment By Investing.com - Investing.com
GRAIL stock jumps after Samsung partnership to bring cancer test to Asia - Investing.com
Grail Inc stock hits all-time high at 75.56 USD - Investing.com
Will GRAIL LLC stock deliver better than expected guidance2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Why GRAIL Inc. (NL0) stock could rally strongly2025 Big Picture & Breakout Confirmation Trade Signals - newser.com
President Joshua Ofman Sold A Bunch Of Shares In GRAIL - simplywall.st
GRAIL (NASDAQ:GRAL) Hits New 52-Week HighHere's Why - MarketBeat
The holy grail of modern marketing - Fast Company
11,400 Shares in GRAIL, Inc. $GRAL Purchased by Trifecta Capital Advisors LLC - MarketBeat
CRCM LP Reduces Stake in GRAIL Inc.: A Strategic Portfolio Adjustment - GuruFocus
GRAIL (NASDAQ:GRAL) President Sells $5,086,562.50 in Stock - MarketBeat
GRAIL (NASDAQ:GRAL) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Recent Developments Impacting GRAL - timothysykes.com
GRAIL (NASDAQ:GRAL) Trading Up 7.6%Here's Why - MarketBeat
Do Insider Sales at GRAIL (GRAL) Hint at Shifting Management Confidence Amid Revenue Growth? - simplywall.st
GRAIL (GRAL): Evaluating Valuation After 20% Revenue Growth and Modest Share Price Gains - Yahoo Finance
Slow Capital Inc. Raises Stock Holdings in GRAIL, Inc. $GRAL - MarketBeat
GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Path to a Healthier Future with a Market Cap of $2.22 Billion - DirectorsTalk Interviews
GRAIL (NASDAQ:GRAL) Trading Down 4% Following Insider Selling - MarketBeat
Liquid Biopsy for Early Cancer Detection and Monitoring - GlobeNewswire
Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - Yahoo Finance
Why GRAIL Inc. (NL0) stock stays on top picksTrade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Insider Sell: Joshua Ofman Sells 9,692 Shares of GRAIL Inc (GRAL) - GuruFocus
Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data! - ts2.tech
Grail price target raised to $75 from $43 at Canaccord - TipRanks
How GRAIL Inc. (NL0) stock trades under stagflationEarnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Grail Inc stock hits all-time high of 64.0 USD By Investing.com - Investing.com Nigeria
Grail Inc stock hits all-time high of 64.0 USD - Investing.com India
GRAIL Inc Signs New Headquarters Lease Agreement - MSN
Making Sense of the Numbers: Interpreting Multi-Cancer Early Detection Test Performance - MarketScreener
GRAIL Inc. (GRAL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Grail: A Speculative Buy (NASDAQ:GRAL) - Seeking Alpha
Will GRAL’s Latest Spike Sustain? - timothysykes.com
GRAIL (NASDAQ:GRAL) Stock Price Up 7.2%Still a Buy? - MarketBeat
Why Is GRAIL Stock Rising? - StocksToTrade
Illumina, Grail Beat Investor Suit Over Doomed Acquisition (2) - Bloomberg Law News
What drives GRAIL Inc NL0 stock priceCovered Call Writing & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Grail Inc Azioni (GRAL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):